ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 382 • 2017 ACR/ARHP Annual Meeting

    Radiological Features Identified in the Hands of Children with Down Syndrome and Inflammatory Arthritis

    Charlene Foley1, Emma Jane Mac Dermott1, Aisling Snow2 and Orla G Killeen1, 1National Centre for Paediatric Rheumatology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland, 2Radiology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland

    Background/Purpose: Down’s Arthritis (DA) is an inflammatory joint condition affecting children with Down syndrome (DS). It is 18-21 times more common than JIA in the…
  • Abstract Number: 383 • 2017 ACR/ARHP Annual Meeting

    Immunogenicity of 13 Valent Pneumococcal Vaccine in Children with Lupus: Single Center Experience in South Texas

    Elissa Gonzalez, Joe Cole and Mark Gorelik, Pediatrics, Baylor College of Medicine/Children's Hospital of San Antonio, San Antonio, TX

    Background/Purpose: Pneumococcal vaccination is an important part of the care of pediatric and adult patients with systemic lupus erythematosus, and is recommended as a quality…
  • Abstract Number: 384 • 2017 ACR/ARHP Annual Meeting

    Protection Against Hepatitis B in Immunocompromised Pediatric Rheumatology and Gastroenterology Patients

    Najla Aljaberi1, Emily A. Smitherman2, Enas Ghulam3, Allen Watts2, Dana MH Dykes4 and Jennifer L. Huggins5, 1Pediatric rheumatology, Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Environmental health and biostatistics, Department of Environmental Health, University of Cincinnati, Division of Biostatistics and Epidemiology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 4Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Hepatitis B infection remains a significant public health challenge, particularly for patients on chronic immunosuppressive therapy, due to a considerable mortality risk associated with…
  • Abstract Number: 385 • 2017 ACR/ARHP Annual Meeting

    Reliable Implementation of a Hepatitis B Serology Screening and Vaccination Process for Immunocompromised Pediatric Rheumatology Patients

    Emily A. Smitherman1, Adam Furnier2, Allen Watts1, Sandra Kramer1, Elizabeth Joy Baker1, Dana MH Dykes3, Rebecca Brady4 and Jennifer L. Huggins5, 1Pediatric Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 3Gastroenterology, Hepatology, and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 4Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 5Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Vaccine-preventable infections, including reactivation of hepatitis B virus, are a leading cause of morbidity and mortality in immunocompromised patients. Guidelines recommend that all immunosuppressed…
  • Abstract Number: 386 • 2017 ACR/ARHP Annual Meeting

    Analysis of the Effectiveness of Immunization with Pneumococcal Polysaccharide Vaccine in Children with Juvenile Idiopathic Arthritis

    Ekaterina Alexeeva1,2, Tatiana Dvoryakovskaya1, Rina Denisova1, Olga Lomakina1, Ksenia Isaeva1, Margarita Soloshenko1, Anna Karaseva1, Nikolay Mayansky3, Irina Zubkova3, Darija Novikova4, Anna Gayvoronskaya4, Natalia Tkachenko4, Marika Ivardava4, Firuza Shakhtakhtinskaya4 and Marina Fedoseenko4, 1Reumatology department, Federal State Autonomous Institution"National Scientific and Practical Center of Children's Health"Of the Ministry of Health of the Russian Federation, Moscow, Russian Federation, 2Pediatrics, The Federal State Autonomous Educational Institution of Higher Education The First Moscow State Medical University named after I.M. Sechenov Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russian Federation, 3Clinical laboratory, Federal State Autonomous Institution"National Scientific and Practical Center of Children's Health"Of the Ministry of Health of the Russian Federation, Moscow, Russian Federation, 4Department of Vaccine Prevention, Federal State Autonomous Institution"National Scientific and Practical Center of Children's Health"Of the Ministry of Health of the Russian Federation, Moscow, Russian Federation

    Background/Purpose: Juvenile idiopathic arthritis (JIA) is one of the most frequent and most disabling rheumatic diseases in childhood. Children suffering from JIA receiving immunosuppressive and…
  • Abstract Number: 387 • 2017 ACR/ARHP Annual Meeting

    F4/80hi Synovial Macrophages in the Pathogeneses of Spontaneous Inflammatory Arthritis in CD11c-Flip-KO (HUPO) Mice

    Qi Quan Huang1,2, Renee E. Doyle2, Philip J. Homan1, Harris Perlman3, Deborah R. WInter4 and Richard M. Pope2, 1Division of Rheumatology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 3Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, 4Department of Medicine Division of Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL

    Background/Purpose: Synovial tissue macrophages (STMs) are critical in the pathogenesis of rheumatoid arthritis (RA). During homeostasis, the majority of murine synovial tissue resident macrophages (TRMs)…
  • Abstract Number: 388 • 2017 ACR/ARHP Annual Meeting

    Induction of Anti-Citrullinated Protein Antibodies By Peptidyl Arginine Deiminase Immunization: A New Model for the Development of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis

    Fanny Arnoux1,2, Nathalie Lambert1,3, Nathalie Balandraud1,2,4, Jean Roudier1,3,5 and Isabelle Auger1,2, 1Aix Marseille University, Marseille, France, 2INSERM UMRs 1097, Marseille, France, 3Arthrites auto-immunes, INSERM UMRs 1097, Marseille, France, 4APHM, Marseille, France, 5Rheumatology dept, APHM, Marseille, France

    Background/Purpose: The most important immunological event in rheumatoid arthritis (RA) is the development of anti-citrullinated protein autoantibodies (ACPAs). ACPAs are present in 2/3 of patients.…
  • Abstract Number: 389 • 2017 ACR/ARHP Annual Meeting

    S-110483 a New Potent EP4 Receptor Antagonist with Immunomodulatory and Analgesic Activities

    Takashi Maeda1, Toshitaka Ochiai2, Toshie Nagayasu-Tanaka1, Yuta Morisaki1, Haruka Takizawa1, Seiji Ishihara1, Shigeo Kurokawa1, Kiyoharu Ukai1 and Masahiro Suda1, 1Pharmacology Department, Kaken Pharmaceutical Co., LTD, Kyoto, Japan, 2Kaken Pharmaceutical Co., LTD, Kyoto, Japan

    Background/Purpose: Prostaglandin (PG) E2 is known to enhance the expansion of T helper 17 (Th17) cell population via EP4 receptor (EP4) in the early phase…
  • Abstract Number: 390 • 2017 ACR/ARHP Annual Meeting

    S-110483, a Novel and Selective EP4 Receptor Antagonist with Anti-Bone Destruction Activities

    Toshitaka Ochiai1, Takashi Maeda2, Toshie Nagayasu-Tanaka2, Jun Anzai1, Daiki Kato1, Yuta Morisaki2, Kiyoharu Ukai2 and Masahiro Suda2, 1Kaken Pharmaceutical Co., LTD, Kyoto, Japan, 2Pharmacology Department, Kaken Pharmaceutical Co., LTD, Kyoto, Japan

    Background/Purpose: S-110483 is our novel potent and selective EP4 receptor (EP4) antagonist. In addition to the well-known fact that EP4 antagonists have anti-inflammatory effects, it…
  • Abstract Number: 391 • 2017 ACR/ARHP Annual Meeting

    Defective Glucose and Lipid Metabolism in Rheumatoid Arthritis Is Determined By Chronic Inflammation in Metabolic Tissues

    Nuria Barbarroja1, Ivan Arias de la Rosa2, Sergio Rodriguez-Cuenca3, Yolanda Jiménez-Gómez1, Patricia Ruiz-Limon2, Carlos Perez-Sanchez1, Maria Carmen Abalos-Aguilera2, Irene Cecchi2, Rafaela Ortega-Castro1, Jerusalem Calvo-Gutierrez1, Rocio Guzman-Ruiz4, Maria del Mar Malagon5, Eduardo Collantes-Estévez1, Antonio Vidal-Puig3, Alejandro Escudero-Contreras2 and Chary Lopez-Pedrera1, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbroke’s Hospital, University of Cambridge, Cambridge, United Kingdom, 4Department of Cell Biology, Physiology, and Immunology,, IMIBIC/University of Córdoba/Reina Sofía University Hospital, Cordoba, Spain, 5Department of Cell Biology, Physiology, and Immunology,I, IMIBIC/University of Córdoba/Reina Sofía University Hospital, Cordoba, Spain

    Background/Purpose: Rheumatoid arthritis (RA) patients are at higher risk for insulin resistance (IR). The association between RA and IR, and its role on the different…
  • Abstract Number: 392 • 2017 ACR/ARHP Annual Meeting

    Effects of Synthetic Dmards on the Insulin Resistance and Obesity Associated with Rheumatoid Arthritis: An Obese Mouse Model of Arthritis

    Nuria Barbarroja1, Ivan Arias de la Rosa2, Miriam Ruiz-Ponce1, Sergio Rodriguez-Cuenca3, Maria Carmen Abalos-Aguilera2, Yolanda Jiménez-Gómez1, Patricia Ruiz-Limon2, Carlos Perez-Sanchez1, Eduardo Collantes-Estévez1, Antonio Vidal-Puig3, Alejandro Escudero-Contreras2 and Chary Lopez-Pedrera1, 1Rheumatology service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 2Rheumatology Service, IMIBIC/Reina Sofia Hospital/University of Cordoba, Cordoba, Spain, 3Metabolic Research Laboratories, Wellcome Trust-MRC Institute of Metabolic Science, Addenbroke’s Hospital, University of Cambridge, Cambridge, United Kingdom

    Background/Purpose: Numerous studies have demonstrated the closely association between rheumatoid arthritis (RA) and metabolic complications such as obesity and insulin resistance (IR). Thus, there is…
  • Abstract Number: 393 • 2017 ACR/ARHP Annual Meeting

    The Role of Follicular Helper 17 T Cells in Glucose-6-Phosphate Isomerase Induced Arthritis

    Izumi Kurata, Isao Matsumoto, Atsumu Osada, Hiroshi Ebe, Hoshimi Kawaguchi, Yuya Kondo, Hiroto Tsuboi and Takayuki Sumida, Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

    Background/Purpose: Follicular helper T (Tfh) cell is a novel T cell subset which promotes follicular B cell activation, differentiation to plasma cell and antibody production.…
  • Abstract Number: 394 • 2017 ACR/ARHP Annual Meeting

    Female Tumor Necrosis Factor Transgenic Mice Have More Severe Arthritis Than Males and Supporessed Levels of Bifidobacterium Pseudolongum in Their Gut Microbiome

    Emily Wu1, Richard Bell2, Alex Grier3, Steven Gill4, Edward Schwarz5 and Homaira Rahimi6, 1Department of Immunology, Microbiology, and Virology, University of Rochester, Rochester, NY, 2Center for Musculoskelatal Research, University of Rochester, Rochester, NY, 3Rochester Genomics Center, University of Rochester, Rochester, NY, 4Genomics Research Center, University of Rochester, Rochester, NY, 5Orthopedeatrics, University of Rochester, Rochester, NY, 6Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY

    Background/Purpose: Rheumatoid arthritis (RA) has an increased prevalence and severity in women compared to men, yet the underlying etiology of this sexual dimorphism is unknown.…
  • Abstract Number: 395 • 2017 ACR/ARHP Annual Meeting

    Pharmacological and Safety Profiles of Cyclin-Dependent Kinase 4/6 Inhibitor, Candidate for Development As Rheumatoid Arthritis Therapeutic Option

    Johji Nomura1, Shunsuke Tsujimoto2, Kei Tamura2, Wataru Yamamoto2, Hiroshi Takahashi2, Kyohei Horie2, Toshiya Mashiko2, Naoki Hase2 and Tsunefumi Kobayashi2, 1Teijin Institute for Bio-medical Research, TEIJIN PHARMA LIMITED, Tokyo, Japan, 2TEIJIN PHARMA LIMITED, Tokyo, Japan

    Background/Purpose: The pathogenesis of rheumatoid arthritis (RA) is characterized by the infiltration of immune cells into the synovial tissues and the excessive proliferation of synovial…
  • Abstract Number: 396 • 2017 ACR/ARHP Annual Meeting

    Phospho-STAT1 Inhibition Is the Initial Step after Tofacitinib Treatment in Rabbits with Severe Chronic Synovitis

    Sandra Pérez-Baos, Paula Gratal, Juan Ignacio Barrasa, Ana Lamuedra, Gabriel Herrero-Beaumont and Raquel Largo, Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz UAM, Madrid, Spain

    Background/Purpose: Tofacitinib (TOFA) is a Janus Kinase (Jak) inhibitor approved for the treatment of rheumatoid arthritis (RA) 1. It has recently been shown to selectively…
  • « Previous Page
  • 1
  • …
  • 1229
  • 1230
  • 1231
  • 1232
  • 1233
  • …
  • 2425
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology